VEGFC and myocardial infarction: A combined delivery of lymphatic endothelial progenitor cells (LEPCs) and VEGF-C with the functionalized self-assembling peptide (SAP), or delivery of SAP-thymosin β4 (Tβ4) has shown to be effective for enhancing cardiac lymphangiogenesis after MI, reducing cardiac inflammation and edema, attenuating reverse myocardial remodeling, and improving cardiac function and repair of the infarcted myocardium [132, 133].